Sapphire Star Partners’s Merck MRK Stock Holding History

Sapphire Star Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$1.97M	Buy	27,000 +4,299	+19%	+$303K	2.64%	8
2018 Q3	$1.54M	Sell	22,701 -11,149	-33%	-$710K	1.54%	15
2018 Q2	$1.96M	Sell	33,850 -1,152	-3%	-$65K	2.02%	10
2018 Q1	$1.82M	Sell	35,002 -3,983	-10%	-$215K	2.01%	10
2017 Q4	$2.09M	Sell	38,985 -12,052	-24%	-$668K	2.48%	7
2017 Q3	$3.12M	Sell	51,037 -10,690	-17%	-$648K	4.04%	8
2017 Q2	$3.77M	Sell	61,727 -1,467	-2%	-$89.3K	4.78%	8
2017 Q1	$3.83M	Sell	63,194 -3,568	-5%	-$216K	4.36%	7
2016 Q4	$3.75M	Sell	66,762 -4,103	-6%	-$240K	4.17%	8
2016 Q3	$4.22M	Sell	70,865 -2,390	-3%	-$140K	5.09%	7
2016 Q2	$4.03M	Sell	73,255 -59,135	-45%	-$3.15M	5.15%	6
2016 Q1	$6.67M	Buy	132,390 +66,195	+100%	+$3.24M	5.29%	6
2015 Q4	$3.34M	Buy	+66,195	New	+$3.34M	4.42%	7

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sapphire Star Partners's MRK Position: Q4 2018 in Review

Sapphire Star Partners increased its Merck (MRK) stake by 19% in Q4 2018, buying an estimated $303K and bringing the position to 27,000 shares worth $1.97M. The position accounts for 2.64% of the portfolio, ranked #8.

Sapphire Star Partners first reported a position in MRK in Q4 2015 and has held it in 13 quarters since. The position peaked at $6.67M in Q1 2016. 2,251 funds tracked by Wall St. Rank hold MRK as of Q4 2018.

Sapphire Star Partners held 27,000 shares of Merck worth $1.97M as of Q4 2018.
Sapphire Star Partners bought 4,299 Merck shares in Q4 2018, an estimated $303K.
Merck made up 2.64% of Sapphire Star Partners's portfolio in Q4 2018, its #8 holding.
Sapphire Star Partners first reported a position in Merck in Q4 2015 and has held it in 13 quarters since.
Sapphire Star Partners's Merck position peaked at $6.67M in Q1 2016.
2,251 funds tracked by Wall St. Rank held Merck as of Q4 2018.

Based on Sapphire Star Partners's 13F filing for Q4 2018, filed 12 Feb 2019.